British Association for Psychopharmacology consensus guidance on the use of psychotropic medication preconception, in pregnancy and postpartum 2017

R. Hamish Mcallister-Williams*, David S. Baldwin, Roch Cantwell, Abby Easter, Eilish Gilvarry, Vivette Glover, Lucian Green, Alain Gregoire, Louise M. Howard, Ian Jones, Hind Khalifeh, Anne Lingford-Hughes, Elizabeth McDonald, Nadia Micali, Carmine M. Pariante, Lesley Peters, Ann Roberts, Natalie C. Smith, David Taylor, Angelika WieckLaura M. Yates, Allan H. Young

*Corresponding author af dette arbejde
170 Citationer (Scopus)

Abstract

Decisions about the use of psychotropic medication in pregnancy are an ongoing challenge for clinicians and women with mental health problems, owing to the uncertainties around risks of the illness itself to mother and fetus/infant, effectiveness of medications in pregnancy and risks to the fetus/infant from in utero exposure or via breast milk. These consensus guidelines aim to provide pragmatic advice regarding these issues. They are divided into sections on risks of untreated illness in pregnancy; general principles of using drugs in the perinatal period; benefits and harms associated with individual drugs; and recommendations for the management of specific disorders.

OriginalsprogEngelsk
TidsskriftJournal of psychopharmacology
Vol/bind31
Udgave nummer5
Sider (fra-til)519-552
Antal sider34
ISSN0269-8811
DOI
StatusUdgivet - 1 maj 2017
Udgivet eksterntJa

Fingeraftryk

Dyk ned i forskningsemnerne om 'British Association for Psychopharmacology consensus guidance on the use of psychotropic medication preconception, in pregnancy and postpartum 2017'. Sammen danner de et unikt fingeraftryk.

Citationsformater